Early Systemic Sclerosis: Serum Profiling of Factors Involved in Endothelial, T-cell, and Fibroblast Interplay is Marked by Elevated Interleukin-33 Levels

2013 Classification Criteria for Systemic Sclerosis: An American College of Rheumatology/European League Against Rheumatism Collaborative Initiative

(2013) Frank van den Hoogen et al.   ARTHRITIS AND RHEUMATISM

Agonistic anti-ICAM-1 antibodies in scleroderma: Activation of endothelial pro-inflammatory cascades

(2013) Sabine I. Wolf et al.   VASCULAR PHARMACOLOGY

Early systemic sclerosis: marker autoantibodies and videocapillaroscopy patterns are each associated with distinct clinical, functional and cellular activation markers

(2013) Gabriele Valentini et al.   ARTHRITIS RESEARCH & THERAPY

Increased serum IL-33 levels may indicate vascular involvement in systemic sclerosis

(2012) Sarah Terras et al.   ANNALS OF THE RHEUMATIC DISEASES

“To Be or Not To Be,” Ten Years After: Evidence for Mixed Connective Tissue Disease as a Distinct Entity

(2012) Susanna Cappelli et al.   SEMINARS IN ARTHRITIS AND RHEUMATISM

The Immune Pathogenesis of Scleroderma: Context Is Everything

(2012) Matthew B. Greenblatt et al.   Current Rheumatology Reports

An investigation of the inflammatory cytokine and chemokine network in systemic sclerosis

(2011) V. Codullo et al.   ANNALS OF THE RHEUMATIC DISEASES

Increased circulating levels of interleukin 33 in systemic sclerosis correlate with early disease stage and microvascular involvement

(2011) M. Manetti et al.   ANNALS OF THE RHEUMATIC DISEASES

Role of IL-13 in systemic sclerosis

(2011) Patrizia Fuschiotti   CYTOKINE

Cell Adhesion Molecules Regulate Fibrotic Process via Th1/Th2/Th17 Cell Balance in a Bleomycin-Induced Scleroderma Model

(2010) A. Yoshizaki et al.   JOURNAL OF IMMUNOLOGY

Early systemic sclerosis: assessment of clinical and pre-clinical organ involvement in patients with different disease features

(2010) G. Valentini et al.   RHEUMATOLOGY

Peripheral T cells from patients with early systemic sclerosis kill autologous fibroblasts in co-culture: is T-cell response aimed to play a protective role?

(2010) R. De Palma et al.   RHEUMATOLOGY

The IL1-like cytokine IL33 and its receptor ST2 are abnormally expressed in the affected skin and visceral organs of patients with systemic sclerosis

(2009) M. Manetti et al.   ANNALS OF THE RHEUMATIC DISEASES

IL-33 Induces IL-13-Dependent Cutaneous Fibrosis

(2009) A. L. Rankin et al.   JOURNAL OF IMMUNOLOGY

The Immunobiology of Systemic Sclerosis

(2008) Y. Stephanie Gu et al.   SEMINARS IN ARTHRITIS AND RHEUMATISM

Cellular and molecular mechanisms of fibrosis

(2007) TA Wynn   JOURNAL OF PATHOLOGY